238 related articles for article (PubMed ID: 33736456)
1. Sex Differences in Nonalcoholic Fatty Liver Disease: Estrogen Influence on the Liver-Adipose Tissue Crosstalk.
Morán-Costoya A; Proenza AM; Gianotti M; Lladó I; Valle A
Antioxid Redox Signal; 2021 Sep; 35(9):753-774. PubMed ID: 33736456
[No Abstract] [Full Text] [Related]
2. NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.
Ballestri S; Nascimbeni F; Baldelli E; Marrazzo A; Romagnoli D; Lonardo A
Adv Ther; 2017 Jun; 34(6):1291-1326. PubMed ID: 28526997
[TBL] [Abstract][Full Text] [Related]
3. Tissue-specific pathways and networks underlying sexual dimorphism in non-alcoholic fatty liver disease.
Kurt Z; Barrere-Cain R; LaGuardia J; Mehrabian M; Pan C; Hui ST; Norheim F; Zhou Z; Hasin Y; Lusis AJ; Yang X
Biol Sex Differ; 2018 Oct; 9(1):46. PubMed ID: 30343673
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
Rosso C; Kazankov K; Younes R; Esmaili S; Marietti M; Sacco M; Carli F; Gaggini M; Salomone F; Møller HJ; Abate ML; Vilstrup H; Gastaldelli A; George J; Grønbæk H; Bugianesi E
J Hepatol; 2019 Nov; 71(5):1012-1021. PubMed ID: 31301321
[TBL] [Abstract][Full Text] [Related]
5. Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
Lee C; Kim J; Jung Y
Cells; 2019 Oct; 8(10):. PubMed ID: 31619023
[TBL] [Abstract][Full Text] [Related]
6. Sex Dimorphism of Nonalcoholic Fatty Liver Disease (NAFLD) in
Schiffrin M; Winkler C; Quignodon L; Naldi A; Trötzmüller M; Köfeler H; Henry H; Parini P; Desvergne B; Gilardi F
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576136
[TBL] [Abstract][Full Text] [Related]
7. Nuclear receptors and nonalcoholic fatty liver disease.
Cave MC; Clair HB; Hardesty JE; Falkner KC; Feng W; Clark BJ; Sidey J; Shi H; Aqel BA; McClain CJ; Prough RA
Biochim Biophys Acta; 2016 Sep; 1859(9):1083-1099. PubMed ID: 26962021
[TBL] [Abstract][Full Text] [Related]
8. Role of Estrogens in the Regulation of Liver Lipid Metabolism.
Palmisano BT; Zhu L; Stafford JM
Adv Exp Med Biol; 2017; 1043():227-256. PubMed ID: 29224098
[TBL] [Abstract][Full Text] [Related]
9. Menopause and Non-Alcoholic Fatty Liver Disease: A Review Focusing on Therapeutic Perspectives.
Venetsanaki V; Polyzos SA
Curr Vasc Pharmacol; 2019; 17(6):546-555. PubMed ID: 29992886
[TBL] [Abstract][Full Text] [Related]
10. The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD).
Thondam SK; Cuthbertson DJ; Wilding JPH
Peptides; 2020 Mar; 125():170208. PubMed ID: 31759125
[TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling.
Della Torre S
Front Endocrinol (Lausanne); 2020; 11():572490. PubMed ID: 33071979
[TBL] [Abstract][Full Text] [Related]
12. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease.
Lomonaco R; Ortiz-Lopez C; Orsak B; Webb A; Hardies J; Darland C; Finch J; Gastaldelli A; Harrison S; Tio F; Cusi K
Hepatology; 2012 May; 55(5):1389-97. PubMed ID: 22183689
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in Adipose Tissue Dysfunction and Its Role in the Pathogenesis of Non-Alcoholic Fatty Liver Disease.
Wang X; Rao H; Liu F; Wei L; Li H; Wu C
Cells; 2021 Nov; 10(12):. PubMed ID: 34943809
[TBL] [Abstract][Full Text] [Related]
14. Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).
Saeed A; Dullaart RPF; Schreuder TCMA; Blokzijl H; Faber KN
Nutrients; 2017 Dec; 10(1):. PubMed ID: 29286303
[TBL] [Abstract][Full Text] [Related]
15. New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD).
Zhang X; Ji X; Wang Q; Li JZ
Protein Cell; 2018 Feb; 9(2):164-177. PubMed ID: 28643267
[TBL] [Abstract][Full Text] [Related]
16. Estrogens and female liver health.
Chen KL; Madak-Erdogan Z
Steroids; 2018 May; 133():38-43. PubMed ID: 29100781
[TBL] [Abstract][Full Text] [Related]
17. The interplay between metabolic dysregulations and non-alcoholic fatty liver disease in women after menopause.
Robeva R; Mladenović D; Vesković M; Hrnčić D; Bjekić-Macut J; Stanojlović O; Livadas S; Yildiz BO; Macut D
Maturitas; 2021 Sep; 151():22-30. PubMed ID: 34446275
[TBL] [Abstract][Full Text] [Related]
18. Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps.
Lonardo A; Nascimbeni F; Ballestri S; Fairweather D; Win S; Than TA; Abdelmalek MF; Suzuki A
Hepatology; 2019 Oct; 70(4):1457-1469. PubMed ID: 30924946
[TBL] [Abstract][Full Text] [Related]
19. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.
Milić S; Lulić D; Štimac D
World J Gastroenterol; 2014 Jul; 20(28):9330-7. PubMed ID: 25071327
[TBL] [Abstract][Full Text] [Related]
20. Navigating nonalcoholic fatty liver disease (NAFLD): Exploring the roles of estrogens, pharmacological and medical interventions, and life style.
Zuo Q; Park NH; Lee JK; Santaliz-Casiano A; Madak-Erdogan Z
Steroids; 2024 Mar; 203():109330. PubMed ID: 37923152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
